The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a 225,000-square-foot addition to the company’s existing campus off Old Oxford Road.

Merck announced the opening of a new $1 billion vaccine manufacturing facility in Durham, North Carolina, a major development aligning with the company's broader $12 billion U.S. investment ...

Mon, March 17, 2025 Published on Mar. 15, 2025 Published on 2025-03-15T18:24:57+07:00 he Energy and Mineral Resources Ministry projects that construction of a US$1.16 billion ethanol and methanol ...

(RTTNews) - Merck (MRK), known as MSD outside the U.S., and Canada, Tuesday has inaugurated a new $1 billion, 225,000-square-foot vaccine manufacturing facility at its Durham, North Carolina ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of positive results from two pivotal Phase 3 trials of the ...

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas ...

That downside risk was realized by Merck & Co., Inc. (NYSE:MRK) shareholders over the last year, as the share price declined 29%. That's disappointing when you consider the market returned 18%.

Merck has traditionally eschewed large-scale M&A, but has been warming to the concept in recent years, with deals including its $11.5 billion takeover of Acceleron last year and its $2.75 billion ...

Just a few weeks ago, Merck (known as MSD outside North America) paid $425 million to get hold of OncoImmune. The headline of the deal was an experimental COVID-19 drug, but it also claimed rights ...